Across this site, examples of evidence are rated according to their quality and robustness while recommendations are graded in terms of the strength of the evidence that supports them.
High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs), or RCTs with a very low risk of bias. 1++
Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias. 1+
Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias. 1-
High quality systematic reviews of case control or cohort studies
High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is casual.
2++
Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal. 2+
Case control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal. 2-
Non-analytic studies, eg case reports, case series. 3
Expert opinion. 4
Note: The grade of recommendation relates to the strength of the evidence on which the recommendation is based. It does not reflect the clinical importance of the recommendation.
At least one meta-analysis, systematic review of RCTs, or RCT rated as 1++ and directly applicable to the target population; or
A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results.
A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or
Extrapolated evidence from studies rated as 1++ or 1+.
A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or
Extrapolated evidence from studies rated as 2++.
Evidence level 3 or 4; or
Extrapolated evidence from studies rated as 2+.
Recommended best practice based on the clinical experience of the guideline development group